Skip to content

Enteral vs. Oral Nutrition After Pancreatoduodenectomy

Early Enteral vs. Oral Nutrition After Whipple Procedure: a Multicentric Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05042882
Acronym
NUTRIWHI
Enrollment
144
Registered
2021-09-13
Start date
2021-12-12
Completion date
2025-01-13
Last updated
2025-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malnutrition, Pancreaticoduodenectomy, Postoperative Complications

Keywords

Enteral nutrition, Oral nutrition, Pancreatoduodenectomy, Whipple operation, Pancreas surgery, Morbidity

Brief summary

Patients suffering from pancreas cancer as well as patients with chronic pancreatitis or requiring pancreas surgery often are in a compromised nutritional status. Nutritional support should therefore be started early during the postoperative course to prevent further malnutrition, as it is an important risk factor to develop complications. Recently, several studies have shown that early enteral nutrition (EEN) could shorten length of stay, reduce postoperative infections and mortality, and decrease costs when compared with total parenteral nutrition (TPN) in gastrointestinal cancer surgery. After pancreatoduodenectomy (PD), EEN has been shown to reduce early and late complications, infections, and readmission rates. It is nevertheless currently not clear if EEN improves the short-term outcomes after PD compared to oral nutrition. The primary objective of the study is to assess the impact of EEN on postoperative morbidity after PD, according to the Comprehensive Complication Index. Secondary objectives are to assess the impact of EEN on major postoperative complications, according to Clavien classification, specific complications, length of stay, readmission rates, quality of life, metabolic stress and nutritional response after PD.

Interventions

DIETARY_SUPPLEMENTEarly enteral nutrition

Enteral nutrition via nasojejunal tube

Sponsors

University of Lausanne Hospitals
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient scheduled for elective open pancreatoduodenectomy. * Patient ≥18 years old. * Patient at nutritional risk, i.e., with Nutrition Risk Screening (NRS) ≥3. * Signed informed consent.

Exclusion criteria

* Patient not able to give informed consent as documented by signature of consent form (e.g., vulnerable patients). * Enteral feeding already initiated preoperatively. * Language barrier. * Inability to follow the procedures of the study, e.g., due to language problems, psychological disorders (i.e., eating disorders and bipolar disorders), or dementia.

Design outcomes

Primary

MeasureTime frameDescription
Comprehensive Complication IndexPostoperative day 90Index measuring all complications for a patient

Secondary

MeasureTime frameDescription
Specific complications after pancreatoduodenectomyPostoperative day 90SSI, DGE, POPF, PPH, biliary fistula, gastrojejunal anastomosis fistula, pancreatitis
Length of stayUp to 90 daysFrom operation day to hospital discharge
ReadmissionPostoperative day 90Hospital readmission due to surgical complications
Patients' quality of lifePreoperatively and at 30 and 90 days after the operationEORTC questionnaires
Severe postoperative complicationsPostoperative day 90Dindo-Clavien \>II
Body compositionPreoperatively and on the day when patients leave the hospital after the operationBioelectrical impedance analysis
Muscular measurePreoperatively and on the day when patients leave the hospital after the operationHandgrip strength measure
Resting energy expenditureOn postoperative day 5Indirect calorimetry
Metabolic response to enteral nutritionPreoperatively and twice weekly during the first postoperative weekLaboratory results

Countries

France, Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 23, 2026